Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Cheng

Showing results (351-360 of 827) with videos related to

Pageof 83
Sort By:
QJM : Monthly Journal of the Association of Physicians|August 12, 2025
The Association of HPV Vaccination and Risk of Immune-Mediated DiseasesQianru Zhang, Renin Chang, James Cheng-Chung Wei, et al.
Rheumatology (Oxford, England)|September 21, 2022
Brodalumab, an anti-interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 studyTae-Hwan Kim, Mitsumasa Kishimoto, James Cheng-Chung Wei, et al.
Biomed Research International|August 22, 2015
Spine and Rheumatic DiseasesJames Cheng-Chung Wei, Yi Liu, Hsi-Kai Tsou, et al.
Frontiers in Pharmacology|November 14, 2025
Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort studyWeijie Wang, Shiow-Ing Wang, Yang Cheng, et al.
Journal of Clinical Medicine|June 2, 2021
Association between Appendicitis and Incident Systemic SclerosisKuang-Tsu Yang, James Cheng-Chung Wei, Renin Chang, et al.
International Journal of Rheumatic Diseases|August 17, 2022
The long-term persistence of tumor necrosis factor inhibitors in patients with moderate to severe immune-mediated rheumatic diseases: A nation-wide, population-based real-world studyJing-Yang Huang, Pui-Ying Leong, Amy Ker, et al.
Annals of the Rheumatic Diseases|May 22, 2020
Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosusChia-Ying Wu, Magdalene Tan, Jing-Yang Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 3, 2023
In Regard to Cailleteau et alWen-Han Tsai, Ying-Cheng Chen, Yung-Shuo Kao, et al.
The Journal of Rheumatology|January 14, 2004
Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trialJames Cheng-Chung Wei, Tsai Wen Chan, Huey-Shyan Lin, et al.
American Journal of Epidemiology|May 30, 2019
Association of Scrub Typhus With the Risk of Autoimmune Diseases: A Population-Based Cohort StudyKuo-An Chu, Weishan Chen, Chung Y Hsu, et al.
Pageof 83

Showing results (351-360 of 827) with videos related to

Sort By:
Pageof 83
QJM : Monthly Journal of the Association of Physicians|August 12, 2025
The Association of HPV Vaccination and Risk of Immune-Mediated DiseasesQianru Zhang, Renin Chang, James Cheng-Chung Wei, et al.
Rheumatology (Oxford, England)|September 21, 2022
Brodalumab, an anti-interleukin-17 receptor A monoclonal antibody, in axial spondyloarthritis: 68-week results from a phase 3 studyTae-Hwan Kim, Mitsumasa Kishimoto, James Cheng-Chung Wei, et al.
Biomed Research International|August 22, 2015
Spine and Rheumatic DiseasesJames Cheng-Chung Wei, Yi Liu, Hsi-Kai Tsou, et al.
Frontiers in Pharmacology|November 14, 2025
Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort studyWeijie Wang, Shiow-Ing Wang, Yang Cheng, et al.
Journal of Clinical Medicine|June 2, 2021
Association between Appendicitis and Incident Systemic SclerosisKuang-Tsu Yang, James Cheng-Chung Wei, Renin Chang, et al.
International Journal of Rheumatic Diseases|August 17, 2022
The long-term persistence of tumor necrosis factor inhibitors in patients with moderate to severe immune-mediated rheumatic diseases: A nation-wide, population-based real-world studyJing-Yang Huang, Pui-Ying Leong, Amy Ker, et al.
Annals of the Rheumatic Diseases|May 22, 2020
Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosusChia-Ying Wu, Magdalene Tan, Jing-Yang Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 3, 2023
In Regard to Cailleteau et alWen-Han Tsai, Ying-Cheng Chen, Yung-Shuo Kao, et al.
The Journal of Rheumatology|January 14, 2004
Thalidomide for severe refractory ankylosing spondylitis: a 6-month open-label trialJames Cheng-Chung Wei, Tsai Wen Chan, Huey-Shyan Lin, et al.
American Journal of Epidemiology|May 30, 2019
Association of Scrub Typhus With the Risk of Autoimmune Diseases: A Population-Based Cohort StudyKuo-An Chu, Weishan Chen, Chung Y Hsu, et al.
Pageof 83